Search

Throughout history, metal-based coordination compounds have been used for medical purposes, including the treatment of various illnesses like cancer. Since the discovery of cisplatin in 1965, many other metal coordinating complexes have been developed and evaluated, involving metals such as platinum, iron, zinc, ruthenium, gold, silver, titanium, and copper. The goal behind these efforts is to create effective and safe medications. At the moment, there are a lot of studies talking about the use of cytostatic metal complexes, mainly on promising platinum- and non-platinum-based drugs in both preclinical and clinical trials. However, there is a lack of recent comprehensive studies that cover both the chemical and biological aspects of metal-based coordinating molecules in the context of cancer therapy. This review aims to provide a thorough analysis of the coordination chemistry of existing and innovative cytostatic substances. It will include a description of their design and synthesis, as well as a summary of the biochemical reactivity and physicochemical features of potential metal-containing complexes. [ABSTRACT FROM AUTHOR]

Sensing technology is gaining attention and continuously advancing, making it a recommended element of individualized healthcare management. This is due to the powers exhibited by organometallic compounds, which are further enhanced by the field of bioengineering. Organometallic compounds have a wide range of biological activity and find uses in industrial and material science fields. Their unique ability to specifically target and overcome constraints faced by traditional counterparts makes them potential contenders for sensor technology. These compounds are highly sensitive to changes in their environment, allowing them to be utilized as sensors for detecting various chemicals or conditions. Additionally, the versatility of organometallic compounds enables their integration into different sensor platforms, making them suitable for environmental monitoring, medical diagnostics, and industrial quality control. This article provides a comprehensive summary of recent advancements in the design and synthesis of organometallic compounds, with a specific emphasis on their potential use as sensors. It also discusses the changes made to the structure, the processes used for functionalization, the incorporation of microfluidics, and the resulting impact on the materials’ sensing capabilities. These biologically derived methods align with sustainability goals and enhance the affordability, applicability, and effectiveness of sensing. [ABSTRACT FROM AUTHOR]